Mizuho Securities Remains a Buy on Align Tech (ALGN)
Mizuho Securities analyst Steven Valiquette maintained a Buy rating on Align Tech on February 6 and set a price target of $215.00. The company’s shares closed last Friday at $187.60.
Valentine's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Valiquette covers the Healthcare sector, focusing on stocks such as Cardinal Health, Align Tech, and McKesson. According to TipRanks, Valiquette has an average return of 0.0% and a 52.37% success rate on recommended stocks.
In addition to Mizuho Securities, Align Tech also received a Buy from HSBC’s Sidharth Sahoo in a report issued today. However, on February 5, Needham maintained a Hold rating on Align Tech (NASDAQ: ALGN).
Based on Align Tech’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $995.69 million and a net profit of $56.75 million. In comparison, last year the company earned a revenue of $977.87 million and had a net profit of $115.96 million
Read More on ALGN:
Disclaimer & DisclosureReport an Issue
- Align Technology upgraded to Buy from Hold at HSBC
- Leerink upgrades Envista to Outperform on improved growth, execution
- Align Technology Earnings Call: Record Sales, Tight Margins
- Early notable gainers among liquid option names on February 5th
- Align Technology price target raised to $200 from $180 at Evercore ISI
